Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.8% | −7.4% | −1.2% | −12.5% | +13.8% | +19.1% | +85.2% | — | — | +67.0% |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$60 of every $1,000 in CANC is Genmab
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GMABGenmab A/S | Healthcare | 5.95% | $595.46 | 239K | $12.3M |
| 2 | LLYELI Lilly | Healthcare | 5.68% | $568.18 | 8,222 | $11.8M |
| 3 | RVMDRevolution Medicines | Healthcare | 5.27% | $527.36 | 65K | $10.9M |
| 4 | MRKMerck | Healthcare | 5.02% | $501.75 | 72K | $10.4M |
| 5 | ONCBeone Medicines | Healthcare | 4.37% | $436.99 | 22K | $9.1M |
| 6 | NOVN.SWNovartis AG | Healthcare | 4.33% | $432.53 | 55K | $9.0M |
| 7 | COGTCogent Biosciences | Healthcare | 4.22% | $421.93 | 319K | $8.7M |
| 8 | ABBVAbbvie | Healthcare | 3.95% | $394.98 | 28K | $8.2M |
| 9 | EXELExelixis | Healthcare | 3.71% | $371.16 | 115K | $7.7M |
| 10 | CGONCG Oncology | Healthcare | 3.35% | $335.44 | 82K | $6.9M |
| 11 | RHHBYRoche AG | Healthcare | 3.31% | $331.38 | 113K | $6.9M |
| 12 | BBIOBridgebio Pharma | Healthcare | 3.23% | $322.70 | 86K | $6.7M |
| 13 | HALOHalozyme Therapeutics | Healthcare | 2.96% | $296.34 | 64K | $6.1M |
| 14 | BMYBristol-myers Squibb | Healthcare | 2.82% | $281.82 | 93K | $5.8M |
| 15 | ELVNEnliven Therapeutics | Healthcare | 2.75% | $274.87 | 120K | $5.7M |
CANC has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GMAB | Genmab A/S | 5.95% |
| 2 | LLY | ELI Lilly & | 5.68% |
| 3 | RVMD | Revolution Medicines | 5.27% |
| 4 | MRK | Merck & | 5.02% |
| 5 | ONC | Beone Medicines | 4.37% |
| 6 | NOVN.SW | Novartis AG | 4.33% |
| 7 | COGT | Cogent Biosciences | 4.22% |
| 8 | ABBV | Abbvie | 3.95% |
| 9 | EXEL | Exelixis | 3.71% |
| 10 | CGON | CG Oncology | 3.35% |
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| CANC | 0.64 | 0.97 | 24.2% | −13.2% | 0.80 | $99 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 10, 2025 | Dec 11, 2025 | $0.0196 |
| Dec 11, 2024 | Dec 12, 2024 | $0.73 |
| Dec 13, 2023 | Dec 15, 2023 | $0.15 |